Arkolith/Insider Trading/SLNO/Form 4

Huang Michael F.

Sr. VP of Clinical DevelopmentSOLENO THERAPEUTICS INC (SLNO) · full profile →Form 4 · filed Mar 31, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$200K
Net Open-Market Flow
-$200K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2026Sell(S)4K$30.04$128K42K
Mar 27, 2026Sell(S)488$31.72$15K40K
Mar 27, 2026Sell(S)2K$31.04$57K40K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002019992-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML